1. Home
  2. PXLW vs ANEB Comparison

PXLW vs ANEB Comparison

Compare PXLW & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$7.06

Market Cap

42.7M

Sector

Technology

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.11

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
ANEB
Founded
1997
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.7M
46.0M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PXLW
ANEB
Price
$7.06
$1.11
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$14.33
N/A
AVG Volume (30 Days)
102.2K
130.3K
Earning Date
02-11-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,205,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.67
$0.90
52 Week High
$15.42
$3.42

Technical Indicators

Market Signals
Indicator
PXLW
ANEB
Relative Strength Index (RSI) 55.84 26.14
Support Level $6.13 $0.91
Resistance Level $6.84 $1.20
Average True Range (ATR) 0.41 0.19
MACD 0.08 -0.05
Stochastic Oscillator 85.04 15.56

Price Performance

Historical Comparison
PXLW
ANEB

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: